State Street Corp Halozyme Therapeutics, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 6,633,688 shares of HALO stock, worth $303 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

6,633,688

Previous 5,814,207 14.09%

Holding current value

$303 Million

Previous $304 Million 24.66%

% of portfolio

0.02%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$51.3 - $64.42 $42 Million - $52.8 Million	819,481 Added 14.09%	6,633,688 $380 Million
Q2 2024 Aug 14, 2024	SELL	$37.81 - $52.4 $25.4 Million - $35.3 Million	-673,096 Reduced 10.38%	5,814,207 $304 Million
Q1 2024 May 15, 2024	BUY	$33.68 - $41.95 $395,874 - $493,080	11,754 Added 0.18%	6,487,303 $264 Million
Q4 2023 Feb 14, 2024	BUY	$33.32 - $42.1 $8.86 Million - $11.2 Million	266,018 Added 4.28%	6,475,549 $239 Million
Q3 2023 Nov 14, 2023	SELL	$36.46 - $44.03 $10.7 Million - $13 Million	-294,770 Reduced 4.53%	6,209,531 $237 Million
Q2 2023 Aug 14, 2023	BUY	$30.28 - $38.74 $16.6 Million - $21.3 Million	549,526 Added 9.23%	6,504,301 $235 Million
Q1 2023 May 15, 2023	BUY	$32.86 - $55.7 $7.91 Million - $13.4 Million	240,762 Added 4.21%	5,954,775 $227 Million
Q4 2022 Feb 14, 2023	SELL	$40.06 - $59.44 $18.4 Million - $27.3 Million	-459,365 Reduced 7.44%	5,714,013 $325 Million
Q3 2022 Nov 15, 2022	BUY	$38.53 - $51.78 $9.93 Million - $13.3 Million	257,631 Added 4.36%	6,173,378 $244 Million
Q2 2022 Aug 15, 2022	SELL	$37.35 - $48.3 $9.35 Million - $12.1 Million	-250,380 Reduced 4.06%	5,915,747 $260 Million
Q1 2022 May 16, 2022	BUY	$31.97 - $41.06 $9.76 Million - $12.5 Million	305,295 Added 5.21%	6,166,127 $246 Million
Q4 2021 Feb 14, 2022	BUY	$31.82 - $40.75 $9.09 Million - $11.6 Million	285,515 Added 5.12%	5,860,832 $236 Million
Q3 2021 Nov 15, 2021	BUY	$38.47 - $46.42 $15.9 Million - $19.2 Million	413,524 Added 8.01%	5,575,317 $227 Million
Q2 2021 Aug 16, 2021	BUY	$38.84 - $51.31 $4.99 Million - $6.6 Million	128,577 Added 2.55%	5,161,793 $234 Million
Q1 2021 May 17, 2021	SELL	$39.51 - $51.45 $19.5 Million - $25.3 Million	-492,596 Reduced 8.91%	5,033,216 $210 Million
Q4 2020 Feb 16, 2021	BUY	$25.81 - $43.62 $25 Million - $42.3 Million	970,399 Added 21.3%	5,525,812 $236 Million
Q3 2020 Nov 10, 2020	SELL	$25.74 - $29.63 $17.4 Million - $20.1 Million	-677,593 Reduced 12.95%	4,555,413 $120 Million
Q2 2020 Aug 14, 2020	BUY	$16.25 - $26.81 $14.1 Million - $23.3 Million	868,823 Added 19.91%	5,233,006 $140 Million
Q1 2020 May 11, 2020	BUY	$13.9 - $21.83 $60.7 Million - $95.3 Million	4,364,183 New	4,364,183 $78.5 Million

Others Institutions Holding HALO

# of Institutions

542

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.36B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Halozyme Therapeutics, Inc. Transaction History